c-Abl Phosphorylates MFN2 to Regulate Mitochondrial Morphology in Cells under Endoplasmic Reticulum and Oxidative Stress, Impacting Cell Survival and Neurodegeneration
暂无分享,去创建一个
J. Marugan | C. Hetz | N. Inestrosa | F. Llambi | Andrés E. Dulcey | Andrés E Dulcey | Cristian M. Lamaizon | Cristian Valls | Douglas R. Green | Cliff Guy | Gonzalo I. Cancino | Patrick Fitzgerald | Marcin M. Kamiński | Alexis Martinez | Nancy Leal | Brigitte van Zundert | Silvana Zanlungo | Alejandra R. Alvarez | Brigitte van Zundert
[1] H. Motaln,et al. The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies , 2023, Cells.
[2] J. Marugan,et al. c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease , 2023, Frontiers in Aging Neuroscience.
[3] R. Vidal,et al. The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model , 2022, IBRO neuroscience reports.
[4] R. Ichiyama,et al. Caudal–Rostral Progression of Alpha Motoneuron Degeneration in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis , 2022, Antioxidants.
[5] Noel Southall,et al. c-Abl Activation Linked to Autophagy-Lysosomal Dysfunction Contributes to Neurological Impairment in Niemann-Pick Type A Disease , 2022, Frontiers in Cell and Developmental Biology.
[6] T. Tachibana,et al. c-Src-dependent phosphorylation of Mfn2 regulates endoplasmic reticulum-mitochondria tethering , 2022, bioRxiv.
[7] N. Mercuri,et al. Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease , 2021, Progress in Neurobiology.
[8] Apekshya Panda,et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations , 2020, Nucleic Acids Res..
[9] A. Ballabio,et al. c-Abl Inhibition Activates TFEB and Promotes Cellular Clearance in a Lysosomal Disorder , 2020, iScience.
[10] G. Kroemer,et al. Genotoxic stress triggers the activation of IRE1α-dependent RNA decay to modulate the DNA damage response , 2020, Nature Communications.
[11] Gianluca Tomasello,et al. The Protein Imager: a full-featured online molecular viewer interface with server-side HQ-rendering capabilities , 2020, Bioinform..
[12] D. Chan,et al. Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset , 2019, Nature Communications.
[13] A. S. Gavrish,et al. Transmission Electron Microscopy Study of Mitochondria in Aging Brain Synapses , 2019, Antioxidants.
[14] J. Grimm,et al. SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS , 2019, Scientific Reports.
[15] S. Yun,et al. The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson’s disease mouse model , 2018, Human molecular genetics.
[16] P. Pizzo,et al. Mitofusin 2: from functions to disease , 2018, Cell Death & Disease.
[17] Zengqiang Yuan,et al. c-Abl-mediated Drp1 phosphorylation promotes oxidative stress-induced mitochondrial fragmentation and neuronal cell death , 2017, Cell Death & Disease.
[18] C. Hetz,et al. Fine-Tuning ER Stress Signal Transducers to Treat Amyotrophic Lateral Sclerosis , 2017, Front. Mol. Neurosci..
[19] Ahmed Negida,et al. C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease. , 2017, CNS & neurological disorders drug targets.
[20] Ryuji Kaji,et al. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis , 2017, Science Translational Medicine.
[21] Dustin J Maly,et al. Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes. , 2017, Cell metabolism.
[22] C. Hetz,et al. The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial Bioenergetics , 2017, Front. Oncol..
[23] J. Troncoso,et al. Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration. , 2016, The Journal of clinical investigation.
[24] A. Pendergast,et al. Multifunctional Abl kinases in health and disease , 2016, Journal of Cell Science.
[25] Eric Chevet,et al. Proteostasis control by the unfolded protein response , 2015, Nature Cell Biology.
[26] F. Court,et al. Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling , 2015, Front. Cell. Neurosci..
[27] L. Scorrano,et al. Extracellular Regulated Kinase Phosphorylates Mitofusin 1 to Control Mitochondrial Morphology and Apoptosis , 2015, Molecular cell.
[28] Elisa Greotti,et al. Mitofusin 2 ablation increases endoplasmic reticulum–mitochondria coupling , 2015, Proceedings of the National Academy of Sciences.
[29] C. Dieterich,et al. Mitofusin 2 is required to maintain mitochondrial coenzyme Q levels , 2015, The Journal of cell biology.
[30] T. Dawson,et al. The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease , 2014, Scientific Reports.
[31] N. Inestrosa,et al. EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers , 2014, PloS one.
[32] Deming Zhao,et al. c-Abl Tyrosine Kinase Mediates Neurotoxic Prion Peptide-Induced Neuronal Apoptosis via Regulating Mitochondrial Homeostasis , 2014, Molecular Neurobiology.
[33] Jean Y. J. Wang. The Capable ABL: What Is Its Biological Function? , 2014, Molecular and Cellular Biology.
[34] E. Masliah,et al. c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. , 2014, Human molecular genetics.
[35] C. Moussa,et al. Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models. , 2013, Human molecular genetics.
[36] Jun Wang,et al. Role of ABL family kinases in cancer: from leukaemia to solid tumours , 2013, Nature Reviews Cancer.
[37] G. Dorn,et al. PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria , 2013, Science.
[38] Mohanad Mossalam,et al. Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib. , 2012, Molecular pharmaceutics.
[39] F. Urano,et al. c-Abl Inhibition Delays Motor Neuron Degeneration in the G93A Mouse, an Animal Model of Amyotrophic Lateral Sclerosis , 2012, PloS one.
[40] T. Veenstra,et al. Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. , 2012, Molecular cell.
[41] G. Cesareni,et al. Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases? , 2012, International journal of cell biology.
[42] D. Green,et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria. , 2011, Molecular cell.
[43] E. Toledo,et al. c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice , 2011, Neurobiology of Aging.
[44] Jun-bing Wu,et al. The c-Abl-MST1 Signaling Pathway Mediates Oxidative Stress-Induced Neuronal Cell Death , 2011, The Journal of Neuroscience.
[45] A. J. Valente,et al. Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease , 2011, The Journal of Neuroscience.
[46] Benedikt Westermann,et al. Mitochondrial fusion and fission in cell life and death , 2010, Nature Reviews Molecular Cell Biology.
[47] J. Colicelli,et al. ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity , 2010, Science Signaling.
[48] J. Troncoso,et al. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function , 2010, Proceedings of the National Academy of Sciences.
[49] D. Green,et al. Resistance to caspase-independent cell death requires persistence of intact mitochondria. , 2010, Developmental cell.
[50] A. Koleske,et al. Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts , 2009, Journal of Cell Science.
[51] L. Scorrano,et al. Mitofusin-2 regulates mitochondrial and endoplasmic reticulum morphology and tethering: the role of Ras. , 2009, Mitochondrion.
[52] L. Scorrano,et al. Mitofusin 2 tethers endoplasmic reticulum to mitochondria , 2008, Nature.
[53] Julio D Amigo,et al. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann‐Pick type C disease , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[54] N. Inestrosa,et al. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. , 2008, Brain : a journal of neurology.
[55] G. Perkins,et al. Mitochondrial fragmentation in neurodegeneration , 2008, Nature Reviews Neuroscience.
[56] S. Kaech,et al. Culturing hippocampal neurons , 2006, Nature Protocols.
[57] D. Chan. Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.
[58] H. McBride,et al. Activated Mitofusin 2 Signals Mitochondrial Fusion, Interferes with Bax Activation, and Reduces Susceptibility to Radical Induced Depolarization*[boxs] , 2005, Journal of Biological Chemistry.
[59] K. Kosik,et al. Activation of the neuronal c-Abl tyrosine kinase by amyloid-β-peptide and reactive oxygen species , 2004, Neurobiology of Disease.
[60] Kelvin K. Tsai,et al. c-Abl stabilizes p73 by a phosphorylation-augmented interaction. , 2003, Cancer research.
[61] H. Duewel,et al. Two Distinct Phosphorylation Pathways Have Additive Effects on Abl Family Kinase Activation , 2003, Molecular and Cellular Biology.
[62] G. Superti-Furga,et al. Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase , 2003, Cell.
[63] D. Kufe,et al. Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571. , 2003, Molecular pharmacology.
[64] Erik E. Griffin,et al. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development , 2003, The Journal of cell biology.
[65] N. Narula,et al. Targeting of the c-Abl Tyrosine Kinase to Mitochondria in Endoplasmic Reticulum Stress-Induced Apoptosis , 2001, Molecular and Cellular Biology.
[66] W. Miller,et al. The substrate specificity of the catalytic domain of Abl plays an important role in directing phosphorylation of the adaptor protein Crk. , 2000, Cellular signalling.
[67] L. Tsai,et al. Cables Links Cdk5 and c-Abl and Facilitates Cdk5 Tyrosine Phosphorylation, Kinase Upregulation, and Neurite Outgrowth , 2000, Neuron.
[68] D. Baltimore,et al. Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation , 1998, Neuron.
[69] R. Weichselbaum,et al. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage , 1996, Nature.
[70] C. Sawyers,et al. The nuclear tyrosine kinase c-abl negatively regulates cell growth , 1994, Cell.
[71] P. J. Welch,et al. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.
[72] P. Chinnery,et al. Disturbed mitochondrial dynamics and neurodegenerative disorders , 2015, Nature Reviews Neurology.
[73] R. Bowser,et al. Altered subcellular distribution of c-Abl in Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[74] J. Zhu,et al. Death by Abl: a matter of location. , 2004, Current topics in developmental biology.
[75] M. Zachary,et al. Department of , 1993 .